Literature DB >> 17991090

Fluoromethylcholine PET in recurrent multifocal hepatoma.

N P Lenzo1, J Anderson, A Campbell, L Morandeau, T R De Grado.   

Abstract

F-18 fluorodeoxyglucose (FDG) positron emission tomography (PET) has variable efficacy in evaluating hepatocellular carcinoma. We present a case of a new oncologic imaging tracer fluoromethylcholine (FCH), which has visualized recurrent multifocal hepatoma in a patient with a poor FDG avid hepatic tumour. The lesions demonstrated on FCH PET correlated well with the findings on CT hepatic angiography.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17991090     DOI: 10.1111/j.1440-1673.2007.01802.x

Source DB:  PubMed          Journal:  Australas Radiol        ISSN: 0004-8461


  2 in total

1.  Transport and metabolism of radiolabeled choline in hepatocellular carcinoma.

Authors:  Yu Kuang; Nicolas Salem; David J Corn; Bernadette Erokwu; Haibin Tian; Fangjing Wang; Zhenghong Lee
Journal:  Mol Pharm       Date:  2010-09-21       Impact factor: 4.939

2.  Diagnostic role of radiolabelled choline PET or PET/CT in hepatocellular carcinoma: a systematic review and meta-analysis.

Authors:  Francesco Bertagna; Mattia Bertoli; Giovanni Bosio; Giorgio Biasiotto; Ramin Sadeghi; Raffaele Giubbini; Giorgio Treglia
Journal:  Hepatol Int       Date:  2014-09-03       Impact factor: 6.047

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.